Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
13/08/2026 12:29
BRIEF-Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing Aug 13 (Reuters) - Pelthos Therapeutics Inc PTHS.A:
PELTHOS THERAPEUTICS - FINANCIAL STATEMENTS SHOULD NO LONGER BE RELIED UPON FOR QUARTER ENDED MARCH 31- SEC FILING
PELTHOS THERAPEUTICS - TO RESTATE FINANCIAL STATEMENTS FOR AFFECTED PERIOD
PELTHOS THERAPEUTICS - RESTATEMENT WILL NOT IMPACT LIQUIDITY OR CASH POSITION FOR QUARTER ENDED MARCH 31, 2026 - SEC FILING
PELTHOS THERAPEUTICS - IDENTIFIES MATERIAL WEAKNESS IN INTERNAL CONTROL AS OF MARCH 31, 2026 - SEC FILING
Source text: [ID:n0001919246-26-000110]
Further company coverage: PTHS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pelthos Therapeutics
See all newsPelthos Therapeutics falls as co says will restate Q1 financial statements
Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoption
Brief: Pelthos Therapeutics Announces CFO Transition
Brief: Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain